AI assistant
NOBLEOAK LIFE LIMITED — Director's Dealing 2021
Oct 25, 2021
65433_rns_2021-10-25_dbfd25cf-6234-4f31-99d2-67972c213fdd.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NobleOak Life Limited
ABN 85 087 648 708
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| We (the entity) give ASX the followingthe director for the purposes of section | information under listing rule 3.19A.2 and as agent for205G of the Corporations Act. |
|---|---|
| Name of Director | Anthony Ross Brown |
| Date of last notice | 21 July 2021 (Appendix 3X) |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. | Brohok Investments Co Pty Ltd ACN 000 730530 (an entity associated with Anthony Brown)(“Brohok”) |
| Date of change | 25 October 2021 |
| No. of securities held prior to change | Direct:a) 1,404,145 NOL fully paid ordinary sharesb) 974,623 performance rights (granted undervarious LTIP schemes, not yet vested)c) 273,083 options (granted, not yet exercised)Indirect– Brohok:d) 3,980,769 NOL fully paid ordinary shares |
| Class | a) Ordinary sharesb) Performance Rightsc) Optionsd) Ordinary shares |
| Number acquired | a) 108,396 ordinary shares (which were issuedin respect of vested performance rights) |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1 ME_192089663_1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | Nil |
|---|---|
| Value/Consideration | Estimated at $2.25 per share (estimate based on |
| Note: If consideration is non-cash, provide details andestimated valuation | share price at market close on 22 October 2021) |
| No. of securities held after change | Direct: |
| a) 1,512,541* NOL fully paid ordinary shares | |
| b) 693,561** performance rights (granted, not | |
| yet vested) | |
| c) 273,083 options (granted, not yet exercised) | |
| Indirect– Brohok: | |
| d) 3,980,769 NOL fully paid ordinary shares | |
| * includes 108,396 of the performance rights which | |
| have been exercised and issued as NOL shares | |
| ** 172,666 of the performance rights lapsed and | |
| have been cancelled | |
| Nature of change | Performance rights previously granted under a |
| Example: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment | LTIP have partially vested / lapsed |
| plan, participation in buy-back |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change
- See chapter 19 for defined terms.
Appendix 3Y Page 2 ME_192089663_1
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3 ME_192089663_1